ABCC7 p.Leu441Pro
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 15084988
[PubMed]
Naruse S et al: "A finger sweat chloride test for the detection of a high-risk group of chronic pancreatitis."
No.
Sentence
Comment
51
The 9 CF-causing mutations (R75X, Q98R, M152R, R347H, L441P, L571S, D979A, H1085R, and T1086I) in Japa- nese20,25-28 were screened by SNP typing with Masscode System (Shimadzu, Kyoto, Japan).
X
ABCC7 p.Leu441Pro 15084988:51:54
status: NEW
PMID: 15121783
[PubMed]
Fujiki K et al: "Genetic evidence for CFTR dysfunction in Japanese: background for chronic pancreatitis."
No.
Sentence
Comment
219
The nine CF causing (R75X, Q98R, M152R, R347H, L441P, L571S, D979A, H1085R, and T1086I) and two non-CF causing (Q1352H and R1453W) mutations in Japanese6 22-24 were screened by SNP typing with a Masscode system (Shimadzu, Kyoto, Japan) and confirmed by sequence analysis in positive and equivocal cases.
X
ABCC7 p.Leu441Pro 15121783:219:47
status: NEW
PMID: 20052366
[PubMed]
Gee HY et al: "The L441P mutation of cystic fibrosis transmembrane conductance regulator and its molecular pathogenic mechanisms in a Korean patient with cystic fibrosis."
No.
Sentence
Comment
8
The genetic analysis of patient`s CFTR gene and the related molecular functional study revealed that the patient had a pathogenic L441P mutation in one allele.
X
ABCC7 p.Leu441Pro 20052366:8:130
status: NEW14 J Korean Med Sci 2010; 25: 166-71 ISSN 1011-8934 DOI: 10.3346/jkms.2010.25.1.166 The L441P Mutation of Cystic Fibrosis Transmembrane conductance Regulator and its Molecular Pathogenic Mechanisms in a Korean Patient with Cystic Fibrosis Cystic fibrosis (CF) is an autosomal recessive disorder usually found in populations of white Caucasian descent.
X
ABCC7 p.Leu441Pro 20052366:14:85
status: NEW21 After a comprehensive search for mutations in the CFTR gene, the patient was found to carry the non-synonymous L441P mutation in one allele.
X
ABCC7 p.Leu441Pro 20052366:21:111
status: NEW22 Molecular physiologic analysis of the L441P mutation of CFTR revealed that the L441P mutation completely abolished the CFTR Cl-channel activity by disrupting proper protein folding and membrane trafficking of CFTR protein.
X
ABCC7 p.Leu441Pro 20052366:22:38
status: NEWX
ABCC7 p.Leu441Pro 20052366:22:79
status: NEW23 These results confirmed the pathogenicity of the L441P mutation of CFTR circulating in the Korean population.
X
ABCC7 p.Leu441Pro 20052366:23:49
status: NEW46 Interestingly, a non-synonymous L441P mutation of CFTR was identified in one allele by DGGE and consecutive nucleotide sequencings (Fig. 2).
X
ABCC7 p.Leu441Pro 20052366:46:32
status: NEW49 However, no CFTR mutations including L441P were found in the blood samples from patient`s mother (Fig. 2).
X
ABCC7 p.Leu441Pro 20052366:49:37
status: NEW50 Therefore, the L441P mutation was assumed to come from patient`s father.
X
ABCC7 p.Leu441Pro 20052366:50:15
status: NEW51 It has been reported that the L441P mutation of CFTR is associated with CF in Japan and its allele frequency was estimated around 4.5% among CF patients in Japan (5).
X
ABCC7 p.Leu441Pro 20052366:51:30
status: NEW52 However, the molecular pathogenic mechanisms of the L441P mutation of CFTR are currently unknown.
X
ABCC7 p.Leu441Pro 20052366:52:52
status: NEW53 Therefore, we investigated the disease-causing mechanism of L441P using Fig. 1.
X
ABCC7 p.Leu441Pro 20052366:53:60
status: NEW58 A B A B Patient A WT Band C Lysate Blot: anti-CFTR Ab (M3A7) L441P WT Mother Exon 9 (Ex9.2) L441P 250 CTG → CCG: L441PPatient Forward Reverse T/C A/G T A Forward Reverse Mother Fig. 2.
X
ABCC7 p.Leu441Pro 20052366:58:63
status: NEWX
ABCC7 p.Leu441Pro 20052366:58:94
status: NEW62 (B) Nucleotide sequencing shows that the patient`s CFTR gene contains a mutation changed from T nucleotide at 1454 to C (heterozygous for L441P, CTG:Leu → CCG; Pro).
X
ABCC7 p.Leu441Pro 20052366:62:138
status: NEW63 KDa 160 105 Biotinylation Band B B WT Lysate Blot: anti-calnexin Ab L441P WT L441P 105 KDa 75 Biotinylation Fig. 3.
X
ABCC7 p.Leu441Pro 20052366:63:68
status: NEWX
ABCC7 p.Leu441Pro 20052366:63:77
status: NEW64 Immunoblotting and surface biotinylation of L441P mutant CFTR protein.
X
ABCC7 p.Leu441Pro 20052366:64:44
status: NEW65 HEK 293 cells were transfected with plasmids for wild type CFTR or CFTR carrying the L441P mutation and protein samples were blotted with anti-CFTR M3A7 antibody (Cell Signaling Technology, Danvers, MA).
X
ABCC7 p.Leu441Pro 20052366:65:85
status: NEW66 (A) Most of the wild type CFTR protein was detected as the fully glycosylated mature form (band C), whereas virtually all of the L441P mutant protein appeared as the core-glycosylated form of around 150 kDa (band B).
X
ABCC7 p.Leu441Pro 20052366:66:129
status: NEW71 The CFTR plasmid carrying a L441P mutation was constructed by site-directed mutagenesis using QuickChange kit (Stratagene, La Jolla, CA, USA) with pCMV-CFTR plasmid according to the manufacturer`s protocol.
X
ABCC7 p.Leu441Pro 20052366:71:28
status: NEW73 The total amount of CFTR protein was compared in HEK 293 cells transfected with plasmids for wild type CFTR or CFTR carrying the L441P mutation by immunoblotting of total cell lysates.
X
ABCC7 p.Leu441Pro 20052366:73:129
status: NEW76 In immunoblotting of cell lysates, most of the wild type CFTR protein was detected as the fully glycosylated mature form, whereas virtually all of L441P mutant proteins appeared as the ER core-glycosylated form of about 150 kDa, also known as band B (Fig. 3).
X
ABCC7 p.Leu441Pro 20052366:76:147
status: NEW77 These results imply that the L441P mutant CFTR protein has a defect in the ER-to-Golgi trafficking of the secretory pathway of membrane protein.
X
ABCC7 p.Leu441Pro 20052366:77:29
status: NEW78 Consequently, the surface biotinylation results revealed that the L441P mutant protein failed to reach the plasma membrane, whereas the fully glycosylated form of wild type CFTR was expressed on the cell surface (Fig. 3).
X
ABCC7 p.Leu441Pro 20052366:78:66
status: NEW79 To investigate the intracellular localizations of the mutant CFTR, immunostaining was performed in HEK 293 cells transfected with plasmids for wild type CFTR or CFTR carrying the L441P mutation.
X
ABCC7 p.Leu441Pro 20052366:79:179
status: NEW83 On the other hand, L441P mutant protein was found in the ER, which was confirmed by co-localization with calnexin, an ER membrane protein (Fig. 4).
X
ABCC7 p.Leu441Pro 20052366:83:19
status: NEW89 However, the cAMP treatment (5 μM FSK) failed to activate the Cl- currents in cells transfected with L441P mutant CFTR (Fig. 5).
X
ABCC7 p.Leu441Pro 20052366:89:107
status: NEW95 Immunocytochemistry of L441P mutant CFTR. HEK 293 cells were transfected with plasmids for wild type CFTR or CFTR carrying the L441P mutation, immunostained with anti-CFTR 24-1 antibody (R&D Systems) and fluorescein isothiocyante-conjugated secondary antibodies.
X
ABCC7 p.Leu441Pro 20052366:95:23
status: NEWX
ABCC7 p.Leu441Pro 20052366:95:127
status: NEW98 Wild type Calnexin Merge L441P Calnexin Merge ease progression.
X
ABCC7 p.Leu441Pro 20052366:98:25
status: NEW118 A thorough examination on the coding regions and exon-intron splicing junctions revealed the L441P non-synonymous mutation in one allele.
X
ABCC7 p.Leu441Pro 20052366:118:93
status: NEW128 Fig. 5. cAMP-activated Cl-channel activity of L441P mutant CFTR. HEK 293 cells were transfected with plasmids for wild type CFTR or CFTR carrying the L441P mutation and the cAMP-activated Cl-channel activity was measured in the whole cell configuration.
X
ABCC7 p.Leu441Pro 20052366:128:46
status: NEWX
ABCC7 p.Leu441Pro 20052366:128:47
status: NEW130 Mean currents were normalized as current densities (pA/pF, n=6 for wild type CFTR and n=10 for L441P mutant CFTR).
X
ABCC7 p.Leu441Pro 20052366:130:95
status: NEW132 Currentdensity(pA/pF) 45 40 35 30 25 20 15 10 5 0 2,500 2,000 1,500 1,000 500 -500 -1,000 -1,500 -2,000 -2,500 WT L441P 20 40 60 80 100 120 140 P <0.01 Patch clamp I-V curve pA mV A B -140 -120-100 -80 -60 -40 -20 L441P WT Defects in the protein folding and processing during the secretory pathway of membrane protein are the major molecular pathogenic mechanisms of mutant CFTR (4).
X
ABCC7 p.Leu441Pro 20052366:132:114
status: NEWX
ABCC7 p.Leu441Pro 20052366:132:214
status: NEW134 The present study is the first study that substantially demonstrated the pathogenicity of the L441P mutation.
X
ABCC7 p.Leu441Pro 20052366:134:94
status: NEW135 An integrated molecular physiologic examination revealed that the L441P mutation causes a processing defect.
X
ABCC7 p.Leu441Pro 20052366:135:66
status: NEW136 The L441P mutant protein was not fully glycosylated, which implies that the L441P mutant protein can not travel to the Golgi-complex and subsequently to the membrane.
X
ABCC7 p.Leu441Pro 20052366:136:4
status: NEWX
ABCC7 p.Leu441Pro 20052366:136:76
status: NEW137 This was verified by the absence of L441P mutant protein in the plasma membrane in immunostatining and surface biotinylation experiments.
X
ABCC7 p.Leu441Pro 20052366:137:36
status: NEW138 Consequently, the cAMP-activated chloride channel activities of CFTR were completely deteriorated by the L441P mutation.
X
ABCC7 p.Leu441Pro 20052366:138:105
status: NEW
PMID: 21779199
[PubMed]
Jung H et al: "Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis."
No.
Sentence
Comment
90
del Deletion + - NA NA 7 Q1291X Exon20 4,003 C>T Nonsense Sequencing + - + NA [14] IVS8 T5 Splicing Sequencing - + - NA 8 L88X Exon3 263 T>G Nonsense Sequencing + - NA NA [29] R697KfsX33 Exon13 2,089-2,090 insA Insertion Sequencing - + NA NA 9 L441P Exon9 1,454 T>C Missense Sequencing&DGGE ND - ND NA [19] Abbreviations:IVS,interveningsequence;MLPA,multiplexligation-dependentprobeamplification;ND,notdone;NA,notapplicable;DGGE,denaturinggradientgelelectrophoresis.
X
ABCC7 p.Leu441Pro 21779199:90:244
status: NEW81 The identified mutations included 3 missense mutations (p.Q98R, p.Q1352H, and p.L441P), 3 nonsense mutations (p.Q220X, p.Q1291X, and p.L88X), 1 duplication with frameshift (c.3908dupA), 1 insertion with frameshift (c.2089-2090insA), 4 splice site mutations (c.1766+2T>C, c.3272-26A>G, c.579+5G>A, and IVS8-T5) and 2 deletion mutations (c.2052delA and c.2623-?_2751+?del).
X
ABCC7 p.Leu441Pro 21779199:81:80
status: NEW
PMID: 25553309
[PubMed]
et al: "Erratum: Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis."
No.
Sentence
Comment
7
del Deletion + - NA NA 7 Q1291X Exon 20 4,003 C>T Nonsense Sequencing + - + NA [14] IVS8 T5 Splicing Sequencing - + - NA 8 L88X Exon 3 263 T>G Nonsense Sequencing + - NA NA [29] R697KfsX33 Exon 13 2,089-2,090 insA Insertion Sequencing - + NA NA 9 L441P Exon 9 1,454 T>C Missense Sequencing & DGGE ND - ND NA [19] Abbreviations: IVS, intervening sequence; MLPA, multiplex ligation-dependent probe amplification; ND, not done; NA, not applicable; DGGE, denaturing gradient gel electrophoresis.
X
ABCC7 p.Leu441Pro 25553309:7:247
status: NEW10 del Deletion MLPA + - NA NA 7 Q1291X Exon 20 3,871 C>T Nonsense Sequencing + - + NA [14] IVS8 T5 Splicing Sequencing - + - NA 8 L88X Exon 3 263 T>G Nonsense Sequencing + - NA NA [29] R697KfsX33 Exon 13 2,089 dupA Insertion Sequencing - + NA NA 9 L441P Exon 9 1,322 T>C Missense Sequencing & DGGE ND - ND NA [19] *Nucleotide numbers are based on the CFTR reference mRNA sequence, NM_000492.3.
X
ABCC7 p.Leu441Pro 25553309:10:246
status: NEW